MyBlueDotsNewron and Myung In Pharm Announce License Agreement for evenamide in South Korea MyBlueDots2 weeks ago01 mins MILAN, Italy & MORRISTOWN, New Jersey & SEOUL, Republic of Korea–(BUSINESS WIRE)—- $NWRN #schizophrenia–Newron and Myung In Pharm, South Korea’s leading specialist CNS pharma company, announce license agreement for evenamide in South Korea. Post navigation Previous: Henry Schein Opens Customer Emergency Support Hotline in Response to California FiresNext: What Illinois residents should know, following the first US death from bird virus
People who are autistic and transgender/gender diverse have poorer health and health care, study finds MyBlueDots17 hours ago 0
Digital therapeutics: Exploring the road to commercialization across international markets MyBlueDots21 hours ago 0